Australian National CJD Registry The Florey, Austin Health and Western Health, Melbourne, Australia.
St Vincent's Hospital, Melbourne, Australia.
Neuroradiology. 2024 Nov;66(11):1907-1915. doi: 10.1007/s00234-024-03440-w. Epub 2024 Aug 13.
Sporadic Creutzfeldt-Jakob disease (sCJD) is a frequent differential diagnostic consideration in patients with rapidly progressive dementia (RPD). Fortunately, in the last 2 decades there has been substantial cumulative improvements in sCJD biomarkers, particularly those based on imaging and cerebrospinal fluid (CSF) interrogation. Brain MRI is a very frequently employed investigation in patients with RPD, often utilized quite early in the evaluation and thereby offering a potentially key role in prompting initial concerns for sCJD. Extant conventional MRI criteria for sCJD diagnosis are relatively stringent, requiring fluid attenuated inversion recovery (FLAIR) or diffusion weighted imaging (DWI) high signal changes in 2 or more cortical regions (excluding frontal) or in both the caudate and putamen. Challenging these conventional criteria, a recent publication described improved sensitivity and unchanged specificity if MRI criteria were arguably less rigorous, requiring DWI high signal changes in only 1 or more of 7 discrete brain regions: frontal, parietal, occipital or temporal cortices, as well as the caudate, putamen or thalamus. The aim of the current study was to test the diagnostic performance of this proposed change in MRI criteria in the Australian context and compare it with conventional criteria, as well as 2 other stringent sets of criteria, predicting that a similar improved sensitivity with unchanged specificity would be observed when the proposed criteria were utilized. Sixty-five definite sCJD cases were compared with 63 age- and sex-matched controls. Radiological review of all MRIs applying the different sets of MRI criteria was undertaken by a blinded neuroradiologist, very experienced in CJD interpretation, with independent assessment of 71 MRIs performed by a second blinded neuroradiologist less experienced in sCJD imaging findings. Our study found the sensitivity of the recently proposed MRI criteria (92.3%) to be comparable to that originally reported (90-95%) and also equivalent to the conventional MRI diagnostic criteria (92.3%), while the specificities were also quite similar between the conventional MRI criteria (87.3%) and proposed criteria (85.7%), with the latter lower than previously reported. Negative predictive values and positive predictive values were also very similar between the conventional and proposed MRI criteria. Other MRI criteria assessed were associated with unacceptably low sensitivity for clinical use. Inter-rater reliability as assessed by intra-class correlation coefficients (ICC) revealed moderate reliability for the conventional and proposed MRI criteria, modestly better in the former and when the frontal lobe was retained versus excluded in comparisons.
散发性克雅氏病(sCJD)是快速进展性痴呆(RPD)患者中经常需要鉴别的诊断。幸运的是,在过去的 20 年中,sCJD 生物标志物有了实质性的累积改进,特别是那些基于影像学和脑脊液(CSF)检查的标志物。脑部 MRI 是 RPD 患者经常进行的检查,通常在评估早期就被使用,因此在提示 sCJD 的初始关注方面具有潜在的关键作用。现有的 sCJD 诊断常规 MRI 标准相对严格,需要在 2 个或更多皮质区域(不包括额叶)或在尾状核和壳核中出现液体衰减反转恢复(FLAIR)或弥散加权成像(DWI)高信号改变。挑战这些常规标准,最近的一项研究表明,如果 MRI 标准稍微不严格,即仅在 7 个离散脑区中的 1 个或多个区域(额叶、顶叶、枕叶或颞叶皮质以及尾状核、壳核或丘脑)中出现 DWI 高信号改变,将提高灵敏度且特异性不变。本研究的目的是在澳大利亚环境中检验这种 MRI 标准变化的诊断性能,并将其与常规标准以及另外 2 种严格的标准进行比较,预测当使用建议的标准时,将观察到类似的灵敏度提高而特异性不变。将 65 例明确的 sCJD 病例与 63 例年龄和性别匹配的对照进行比较。由一位对 CJD 解读非常有经验的盲法神经放射科医生对所有 MRI 进行放射学复查,应用不同的 MRI 标准,并由一位对 sCJD 成像结果经验较少的第二位盲法神经放射科医生对 71 份 MRI 进行独立评估。我们的研究发现,最近提出的 MRI 标准(92.3%)的灵敏度与最初报道的(90-95%)相当,也与常规 MRI 诊断标准(92.3%)相当,而特异性在常规 MRI 标准(87.3%)和建议标准(85.7%)之间也非常相似,后者低于先前报道。阴性预测值和阳性预测值在常规和建议的 MRI 标准之间也非常相似。评估的其他 MRI 标准与临床应用的低灵敏度相关。通过组内相关系数(ICC)评估的组间可靠性显示,常规和建议的 MRI 标准具有中等可靠性,前者更好,在比较时保留或排除额叶时更好。